In the June 26, 2024, Customs Bulletin and Decisions, U.S. Customs and Border Protection is reclassifying sildenafil citrate in bulk form as a sulfonamide under HTSUS 2935.90.60 (duty-free under the Pharmaceutical Appendix) rather than as a heterocyclic compound with nitrogen heteroatoms only under HTSUS 2933.59.5300 (duty-free under the Pharmaceutical Appendix).
Ruling HQ H261406 will revoke rulings NY H83763 and NY B87488 to reflect this change, effective with respect to goods entered or withdrawn from warehouse for consumption on or after Aug. 26.
The product at issue is a drug that produces the dilatation of blood vessels and is used to treat erectile dysfunction and high blood pressure in the lungs.
For more information on how to seek or utilize classification and other rulings, please contact attorney Deb Stern at (305) 894-1007 or via email.
Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.